Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:807-812

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kass, D. A.
Right arrow Articles by Calkins, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kass, D. A.
Right arrow Articles by Calkins, H.
Related Collections
Right arrow Congestive
Right arrow Pacemaker
Right arrow Exercise/exercise testing/rehabilitation

(Circulation. 1999;100:807-812.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Ventricular Pacing With Premature Excitation for Treatment of Hypertensive-Cardiac Hypertrophy With Cavity-Obliteration

David A. Kass, MD; Chen-Huan Chen, MD; Maurice W. Talbot, BSN; Carlos E. Rochitte, MD; João A. C. Lima, MD; Ronald D. Berger, MD; Hugh Calkins, MD

From the Division of Cardiology, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence to David A. Kass, MD, Halsted 500, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21287. E-mail dkass{at}bme.jhu.edu

Background—Hypertensive left ventricular hypertrophy with supranormal systolic ejection and distal cavity obliteration (HHCO) can result in debilitating exertional fatigue and dyspnea. Dual-chamber pacing with ventricular preactivation generates discoordinate contraction, which can limit cavity obliteration and thereby increase potential ejection reserve. Accordingly, we hypothesized that pacing may improve exercise tolerance long-term in this syndrome.

Methods and Results—Dual-chamber pacemakers were implanted in 9 patients with exertional dyspnea caused by HHCO. Intrinsic atrial rate was sensed, and ventricular preactivation was achieved by shortening the atrial-ventricular delay. Pacing was on or off for successive 3-month periods (randomized, double-blind, crossover design), followed by 6 additional pacing-on months. Metabolic exercise testing, quality-of-life assessment, and rest and dobutamine-stress echocardiographic/Doppler data were obtained. After 3 months of pacing-on, exercise duration rose from 324±133 to 588±238 s (mean±SD; P=0.001, with 7 of 9 patients improving >=30%), and maximal oxygen consumption increased from 13.6±2.9 to 16.7±3.3 mL of O2 · min-1 · kg-1 (P<0.02). Both parameters were little changed from baseline during the pacing-off period. Improved exercise capacity persisted at 1-year follow-up. Clinical symptoms and activities of daily living improved during the pacing-on period and stayed improved at 1 year, but they were little changed during the pacing-off period. Despite similar basal values, stroke volume (P<0.001) and cardiac output (P<0.02) increased with dobutamine stimulation 2 to 3 times more after 1 year of follow-up as compared with baseline.

Conclusions—Long-term dual-chamber pacing can improve exercise capacity, cardiac reserve, clinical symptoms, and activities of daily living in patients with HHCO. This therapy may provide a novel alternative for patients in whom traditional pharmacological treatment proves inadequate.


Key Words: pacing • hypertension • exercise • hypertrophy • heart failure




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. A. Kass
An epidemic of dyssynchrony: but what does it mean?
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 12 - 17.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Borlaug, V. Melenovsky, S. D. Russell, K. Kessler, K. Pacak, L. C. Becker, and D. A. Kass
Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction
Circulation, November 14, 2006; 114(20): 2138 - 2147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Rosa, J.-P. Maury, J. Terrand, X. Lyon, P. Kucera, L. Kappenberger, and E. Raddatz
Ectopic pacing at physiological rate improves postanoxic recovery of the developing heart
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2384 - H2392.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
Ann. Thorac. Surg., February 1, 2003; 75(2): 620 - 632.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. O'Rourke
Cardiac Pacing : An Alternative Treatment for Selected Patients With Hypertrophic Cardiomyopathy and Adjunctive Therapy for Certain Patients With Dilated Cardiomyopathy
Circulation, August 24, 1999; 100(8): 786 - 788.
[Full Text] [PDF]